BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 21429221)

  • 1. Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis.
    Twarock S; Freudenberger T; Poscher E; Dai G; Jannasch K; Dullin C; Alves F; Prenzel K; Knoefel WT; Stoecklein NH; Savani RC; Homey B; Fischer JW
    Mol Cancer; 2011 Mar; 10():30. PubMed ID: 21429221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells.
    Twarock S; Tammi MI; Savani RC; Fischer JW
    J Biol Chem; 2010 Jul; 285(30):23276-84. PubMed ID: 20463012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperglycaemia and aberrated insulin signalling stimulate tumour progression via induction of the extracellular matrix component hyaluronan.
    Twarock S; Reichert C; Peters U; Gorski DJ; Röck K; Fischer JW
    Int J Cancer; 2017 Aug; 141(4):791-804. PubMed ID: 28493326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3.
    Kultti A; Pasonen-Seppänen S; Jauhiainen M; Rilla KJ; Kärnä R; Pyöriä E; Tammi RH; Tammi MI
    Exp Cell Res; 2009 Jul; 315(11):1914-23. PubMed ID: 19285976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells.
    Nagase H; Kudo D; Suto A; Yoshida E; Suto S; Negishi M; Kakizaki I; Hakamada K
    Pancreas; 2017 Feb; 46(2):190-197. PubMed ID: 27846148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal Squamous Cell Carcinoma Cells Modulate Chemokine Expression and Hyaluronan Synthesis in Fibroblasts.
    Kretschmer I; Freudenberger T; Twarock S; Yamaguchi Y; Grandoch M; Fischer JW
    J Biol Chem; 2016 Feb; 291(8):4091-106. PubMed ID: 26699196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of hyaluronan in oesophageal cancer cells is uncoupled from the prostaglandin-cAMP pathway.
    Twarock S; Röck K; Sarbia M; Weber AA; Jänicke RU; Fischer JW
    Br J Pharmacol; 2009 May; 157(2):234-43. PubMed ID: 19338584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor.
    Ikuta K; Ota T; Zhuo L; Urakawa H; Kozawa E; Hamada S; Kimata K; Ishiguro N; Nishida Y
    Int J Cancer; 2017 Jan; 140(2):469-479. PubMed ID: 27706810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.
    Urakawa H; Nishida Y; Wasa J; Arai E; Zhuo L; Kimata K; Kozawa E; Futamura N; Ishiguro N
    Int J Cancer; 2012 Jan; 130(2):454-66. PubMed ID: 21387290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues.
    Zhang G; Zhang Q; Zhang Q; Yin L; Li S; Cheng K; Zhang Y; Xu H; Wu W
    J Cancer Res Clin Oncol; 2010 Apr; 136(4):587-94. PubMed ID: 19823871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HAS3-related hyaluronan enhances biological activities necessary for metastasis of osteosarcoma cells.
    Tofuku K; Yokouchi M; Murayama T; Minami S; Komiya S
    Int J Oncol; 2006 Jul; 29(1):175-83. PubMed ID: 16773198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hyaluronan synthase-3 decreases subcutaneous colon cancer growth by increasing apoptosis.
    Teng BP; Heffler MD; Lai EC; Zhao YL; LeVea CM; Golubovskaya VM; Bullarddunn KM
    Anticancer Agents Med Chem; 2011 Sep; 11(7):620-8. PubMed ID: 21453239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma.
    Li X; Wu Z; Mei Q; Li X; Guo M; Fu X; Han W
    Br J Cancer; 2013 Oct; 109(8):2266-78. PubMed ID: 24022190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronan synthase 3 mediated oncogenic action through forming inter-regulation loop with tumor necrosis factor alpha in oral cancer.
    Kuo YZ; Fang WY; Huang CC; Tsai ST; Wang YC; Yang CL; Wu LW
    Oncotarget; 2017 Feb; 8(9):15563-15583. PubMed ID: 28107185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone.
    Kakizaki I; Kojima K; Takagaki K; Endo M; Kannagi R; Ito M; Maruo Y; Sato H; Yasuda T; Mita S; Kimata K; Itano N
    J Biol Chem; 2004 Aug; 279(32):33281-9. PubMed ID: 15190064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.
    Lee KW; Sung CO; Kim JH; Kang M; Yoo HY; Kim HH; Um SH; Kim SH
    Int J Cancer; 2015 Jan; 136(2):310-21. PubMed ID: 24895167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan stimulates pancreatic cancer cell motility.
    Cheng XB; Kohi S; Koga A; Hirata K; Sato N
    Oncotarget; 2016 Jan; 7(4):4829-40. PubMed ID: 26684359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE
    Pun IH; Chan D; Chan SH; Chung PY; Zhou YY; Law S; Lam AK; Chui CH; Chan AS; Lam KH; Tang JC
    Cancer Res Treat; 2017 Jan; 49(1):219-229. PubMed ID: 27456944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the hyaluronan matrix enhances metabolic anticancer therapy by dichloroacetate in vitro and in vivo.
    Twarock S; Reichert C; Bach K; Reiners O; Kretschmer I; Gorski DJ; Gorges K; Grandoch M; Fischer JW
    Br J Pharmacol; 2019 Dec; 176(23):4474-4490. PubMed ID: 31351004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.